InvivoSciences launched in 2001 in St. Louis, Missouri with exclusive technology licensed from Washington University in St. Louis.

In 2005, Founders Dr. Tetsuro Wakatsuki, Ayla Annac and Dr. Elliot Elson moved InvivoSciences to Wisconsin.

Why we do what we do?

Our founders’ personal experience drove us to start doing what we do now. Thanks to the US National Institute of Health and generous contributors. Their long-term and extensive support enabled IVS to develop and validate human induced pluripotent stem cell (iPSC) derived micro-heart tissue called NuHeart™. IVS’s core competencies include an automated process of mass-producing micro NuHearts derived from various lines of patient-specific and gene-edited iPSCs and their high-throughput phenotypic assay platform.

InvivoSciences, Inc. (IVS) Videos

Invivo Sciences, LLC Helping to Bring Tomorrow`s Discoveries to Life - Video